Wedge Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Sell |
29,991
-6,993
| -19% | -$442K | 0.03% | 331 |
|
|
2025
Q1 | $1.96M | Sell |
36,984
-11,427
| -24% | -$605K | 0.04% | 329 |
|
|
2024
Q4 | $2.71M | Sell |
48,411
-433
| -0.9% | -$24.2K | 0.05% | 286 |
|
|
2024
Q3 | $2.56M | Sell |
48,844
-14,353
| -23% | -$752K | 0.04% | 292 |
|
|
2024
Q2 | $2.59M | Sell |
63,197
-10,676
| -14% | -$438K | 0.05% | 283 |
|
|
2024
Q1 | $3.2M | Sell |
73,873
-2,634
| -3% | -$114K | 0.05% | 278 |
|
|
2023
Q4 | $3.52M | Sell |
76,507
-28,213
| -27% | -$1.3M | 0.06% | 270 |
|
|
2023
Q3 | $2.4M | Sell |
104,720
-113,705
| -52% | -$2.61M | 0.05% | 291 |
|
|
2023
Q2 | $3.6M | Buy |
+218,425
| New | +$3.6M | 0.06% | 312 |
|